Management of New Oral Anticoagulant Therapy for AFib Following PCI

A 75-year-old man with a history of atrial fibrillation on rivaroxaban (20 mg daily), diabetes, and hypertension presents to the hospital with an anterior ST-elevation myocardial infarction (STEMI). He receives a 325 mg loading dose of aspirin and 600 mg of clopidogrel; rivaroxaban is held and unfractionated heparin is administered. Primary percutaneous coronary intervention (PCI) is performed with drug-eluting stent placement due to long, proximal left anterior descending artery lesion. Creatinine clearance is >60 mL/min and liver enzymes are normal.

Which of the following is the next step in antithrombotic management following PCI?

Show Answer